Ovarian cancer is a highly aggressive disease with a poor prognosis, largely due to challenges in early detection. Traditional screening methods, including transvaginal ultrasound (TVS) and CA125 testing, have notable limitations in detecting early-stage disease and are not advised for widespread use. This article examines emerging early detection technologies, such as novel biomarkers, circulating DNA, PCR assays from Pap swabs, autoantibodies, microRNAs, and advanced imaging techniques. Future advancements in therapeutic methods may enhance survival outcomes linked to early detection. While general population screening remains unendorsed, targeted screening might be valuable for high-risk groups, such as those with Lynch syndrome, but should not replace risk-reducing surgeries. Developing comprehensive screening guidelines for high-risk individuals is essential for improving early detection and survival rates in ovarian cancer.

Background/Objectives: Diabetes mellitus (DM) in pregnancy, including type 1 (T1DM), type 2 (T2DM), and gestational DM (GDM), represents an increasing health burden due to its maternal and fetal complications. Despite the increment in the global prevalence estimates of DM in pregnancy, in Romania, it has not been comprehensively described. This study aimed to analyze the prevalence and dynamics of DM in pregnancy in Romania between 2014 and 2024, using national databases, and to identify prevention strategies for reducing maternal and fetal complications. Methods: Data were obtained from the Romanian National Public Health Institute through two distinct sources: Database 1, consisting of reports from public and medical units associated with the National Health Insurance House and Database 2, based on the reports from general practitioners. Pregnancies complicated by DM were assessed by type, age group, and environmental settlement. Additional data were extracted on pregnancies with insufficient prenatal care and those of socially vulnerable individuals. Results: From 2014 to 2024, the prevalence of DM in pregnancy in Romania was consistently lower than European and global estimates, ranging from 1.01‰ to 3.08‰ in Database 1 and from 0.84‰ to 5.88‰ in Database 2, respectively. GDM accounted for the majority of cases, accounting for 65–88% of reported DM in pregnancy. The highest incidence was observed in the 20–39 years age group, with a growing proportion in women aged ≥40 years. Urban-rural disparities decreased over the decade, with rural cases reaching parity by 2024. Vulnerable populations included adolescents, women with insufficient prenatal care, and those with social risk factors, predominantly from rural areas. Conclusions: Although the reported prevalence of DM in pregnancy in Romania is lower than international figures, the true burden is likely underestimated. GDM remains the leading type of DM in pregnancy, mirroring global trends. Strengthening the reporting system, standardizing diagnostic criteria, and targeting high-risk groups through preconceptional counselling, lifestyle interventions, advanced monitoring technologies, and improving social support through the involved authorities are crucial steps to reduce maternal and fetal morbidity.

Starting from menarche, the onset of the first menstrual period, until menopause, which marks the end of re­pro­duc­tive capabilities, women undergo monthly fluctuations in hor­mones responsible for reproductive regulation. These hor­mones extend their impact beyond direct reproductive func­tions, exerting influences on mood regulation, body temperature, respiration, the autonomic nervous sys­tem, and sleep. Abnormal menstrual symptoms are frequently reported by young women and, concurrently, sleep distur­bances carry broad implications for the health, be­ha­vior and academic performance of individuals, en­com­pas­sing both those generally healthy and those with un­der­lying medical conditions. In contrast to men, women frequently report more sleep disorders and exhibit a higher sus­cep­tibility to insomnia. Premenstrual syndrome and polycystic ovary syndrome (PCOS) disrupt the hormonal balance and are known to alter sleep patterns. Women experiencing sig­ni­fi­cant emotional premenstrual symptoms tend to be sleepier during the late luteal phase compared to those with mi­ni­mal symptoms. PCOS is known to be the most common hor­mo­nal disorder in women of reproductive age. However, sleep hygiene is not frequently included in the treatment recommendations of these patients.